| Treatment of acute hepatitis C with interferon alfa-2b E Jaeckel, M Cornberg, H Wedemeyer, T Santantonio, J Mayer, M Zankel, ... New England Journal of Medicine 345 (20), 1452-1457, 2001 | 1178 | 2001 |
| Early monotherapy with pegylated interferon alpha‐2b for acute hepatitis C infection: the HEP‐NET acute‐HCV‐II study J Wiegand, P Buggisch, W Boecher, S Zeuzem, CM Gelbmann, T Berg, ... Hepatology 43 (2), 250-256, 2006 | 337 | 2006 |
| Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes E Jaeckel, H von Boehmer, MP Manns Diabetes 54 (2), 306-310, 2005 | 305 | 2005 |
| Thymic selection revisited: how essential is it? H Von Boehmer, I Aifantis, F Gounari, O Azogui, L Haughn, I Apostolou, ... Immunological reviews 191 (1), 62-78, 2003 | 286 | 2003 |
| Prevention of allograft rejection by use of regulatory T cells with an MHC-specific chimeric antigen receptor F Noyan, K Zimmermann, M Hardtke-Wolenski, A Knoefel, E Schulde, ... American Journal of Transplantation 17 (4), 917-930, 2017 | 271 | 2017 |
| Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation F Bohne, M Martínez-Llordella, JJ Lozano, R Miquel, C Benítez, ... The Journal of clinical investigation 122 (1), 368-382, 2012 | 220 | 2012 |
| Viruses and diabetes E Jaeckel, M Manns, M Von Herrath Annals of the New York Academy of Sciences 958 (1), 7-25, 2002 | 200 | 2002 |
| Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes M Tenspolde, K Zimmermann, LC Weber, M Hapke, M Lieber, J Dywicki, ... Journal of autoimmunity 103, 102289, 2019 | 163 | 2019 |
| Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies R Taubert, M Hardtke-Wolenski, F Noyan, A Wilms, AK Baumann, ... Journal of hepatology 61 (5), 1106-1114, 2014 | 160 | 2014 |
| Evidence for protein phosphatase inhibitor‐1 playing an amplifier role in β‐adrenergic signaling in cardiac myocytes A El‐Armouche, T Rau, O Zolk, D Ditz, T Pamminger, WH Zimmermann, ... The FASEB journal 17 (3), 1-23, 2003 | 157 | 2003 |
| Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning N Pilat, U Baranyi, C Klaus, E Jaeckel, N Mpofu, F Wrba, D Golshayan, ... American Journal of Transplantation 10 (4), 751-762, 2010 | 155 | 2010 |
| Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes E Jaeckel, MA Lipes, H von Boehmer Nature immunology 5 (10), 1028-1035, 2004 | 154 | 2004 |
| Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin … HL Tillmann, C Trautwein, T Bock, KH Böker, E Jäckel, M Glowienka, ... Hepatology 30 (1), 244-256, 1999 | 148 | 1999 |
| Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer K Kretschmer, I Apostolou, E Jaeckel, K Khazaie, H Von Boehmer Immunological reviews 212 (1), 163-169, 2006 | 131 | 2006 |
| Long‐term follow‐up after successful interferon therapy of acute hepatitis C J Wiegand, E Jäckel, M Cornberg, H Hinrichsen, M Dietrich, J Kroeger, ... Hepatology 40 (1), 98-107, 2004 | 119 | 2004 |
| Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry C Stephens, M Robles-Diaz, I Medina-Caliz, M Garcia-Cortes, ... Journal of hepatology 75 (1), 86-97, 2021 | 114 | 2021 |
| Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase E Jaeckel, L Klein, N Martin-Orozco, H von Boehmer The Journal of experimental medicine 197 (12), 1635-1644, 2003 | 105 | 2003 |
| Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model T Yang, M Poenisch, R Khanal, Q Hu, Z Dai, R Li, G Song, Q Yuan, Q Yao, ... Journal of hepatology 75 (6), 1420-1433, 2021 | 103 | 2021 |
| Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells M Hardtke-Wolenski, K Fischer, F Noyan, J Schlue, CS Falk, M Stahlhut, ... Hepatology 58 (2), 718-728, 2013 | 93 | 2013 |
| Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C B Wesche, E Jaeckel, C Trautwein, H Wedemeyer, A Falorni, H Frank, ... Gut 48 (3), 378-383, 2001 | 92 | 2001 |
